6.3 Nanofluidic devices for drug discovery and delivery
6 min read•august 15, 2024
Nanofluidic devices are revolutionizing drug discovery and delivery. These tiny systems, with channels smaller than 100 nanometers, allow precise control of fluids and molecules. They enable single-molecule detection, mimic body conditions, and speed up drug screening.
These devices are changing how we develop and deliver drugs. They help create targeted therapies, study drug interactions at the molecular level, and design smart delivery systems. This tech is paving the way for personalized medicine, making treatments more effective and tailored to each patient.
Nanofluidic devices for drug discovery and delivery
Principles and advantages of nanofluidic devices
Top images from around the web for Principles and advantages of nanofluidic devices
Frontiers | Nanoscale Self-Assembly for Therapeutic Delivery View original
Is this image relevant?
Frontiers | Nanoscale Drug Delivery Systems: From Medicine to Agriculture View original
Is this image relevant?
Nanofluidic devices prepared by an atomic force microscopy-based single-scratch approach - RSC ... View original
Is this image relevant?
Frontiers | Nanoscale Self-Assembly for Therapeutic Delivery View original
Is this image relevant?
Frontiers | Nanoscale Drug Delivery Systems: From Medicine to Agriculture View original
Is this image relevant?
1 of 3
Top images from around the web for Principles and advantages of nanofluidic devices
Frontiers | Nanoscale Self-Assembly for Therapeutic Delivery View original
Is this image relevant?
Frontiers | Nanoscale Drug Delivery Systems: From Medicine to Agriculture View original
Is this image relevant?
Nanofluidic devices prepared by an atomic force microscopy-based single-scratch approach - RSC ... View original
Is this image relevant?
Frontiers | Nanoscale Self-Assembly for Therapeutic Delivery View original
Is this image relevant?
Frontiers | Nanoscale Drug Delivery Systems: From Medicine to Agriculture View original
Is this image relevant?
1 of 3
- Operate at nanoscale with channel dimensions below 100 nm allowing precise control and manipulation of fluids and molecules
- High surface-area-to-volume ratio enhances surface-dependent phenomena (adsorption and desorption) crucial for drug interactions and delivery mechanisms
- Enable single-molecule detection and analysis providing unprecedented sensitivity for drug screening and pharmacokinetic studies
- Precisely control fluid flow and molecular transport allowing more accurate drug dosing and targeted delivery to specific cells or tissues
- Mimic physiological conditions more accurately than traditional in vitro methods improving relevance of drug discovery experiments and reducing need for animal testing
- Miniaturization of drug discovery and delivery processes leads to reduced reagent consumption, faster analysis times, and higher throughput screening capabilities
- Integrate with other technologies (microfluidics and lab-on-a-chip systems) enabling comprehensive drug development platforms with enhanced functionality and efficiency
Applications in drug discovery and delivery
- Facilitate of drug candidates against target proteins or cells
- Enable detailed studies of drug-target interactions at the molecular level
- Allow for precise control over drug release kinetics in controlled delivery systems
- Support development of strategies by manipulating nanoparticle-drug conjugates
- Provide platforms for studying drug metabolism and pharmacokinetics at the nanoscale
- Enable creation of artificial cell membranes for drug permeability studies
- Assist in formulation development by studying drug-excipient interactions in confined spaces
Fabrication techniques for nanofluidic devices
Lithography and etching techniques
- Photolithography and electron beam lithography pattern with e-beam lithography offering higher resolution for sub-10 nm features
- Reactive ion etching (RIE) and deep reactive ion etching (DRIE) transfer patterns from resist layers to substrate materials creating high-aspect-ratio nanofluidic structures
- Soft lithography techniques (replica molding and microcontact printing) utilized for rapid prototyping and mass production of nanofluidic devices using elastomeric materials (PDMS)
- Nanoimprint lithography (NIL) enables high-throughput fabrication with precise control over channel dimensions and surface properties
- Focused ion beam milling creates complex 3D nanofluidic structures for enhanced functionality
- Two-photon polymerization allows for direct writing of intricate 3D nanofluidic networks
- Interference lithography produces large-area periodic nanostructures for parallel nanofluidic channels
Materials and surface modification
- Common materials include , glass, and polymers (PDMS, PMMA, COC) offering specific advantages in optical properties, chemical resistance, and biocompatibility
- techniques (plasma treatment, chemical vapor deposition, self-assembled monolayers) tailor surface properties of nanofluidic channels for specific biological applications
- Atomic layer deposition enables precise control of surface chemistry and channel dimensions
- Nanoparticle-based coatings enhance surface functionality and introduce novel properties
- Biomolecule immobilization techniques (covalent attachment, affinity-based capture) create biorecognition surfaces
- Stimuli-responsive surface coatings (pH-sensitive, temperature-sensitive) incorporated for on-demand drug release or capture
- Nanostructured surface topographies (nanopillars, nanogrooves) engineered to enhance drug adsorption, cellular interactions, and controlled release kinetics
Challenges of nanofluidic devices
Fabrication and characterization challenges
- Maintaining precise nanoscale dimensions and avoiding channel collapse or deformation impacts device reproducibility and performance
- Integration of nanofluidic devices with macroscale systems for sample introduction and analysis presents challenges in interfacing and flow control across multiple length scales
- Limited throughput of some nanofluidic devices may hinder application in high-volume drug screening processes requiring parallelization or alternative strategies
- Characterization and validation of nanofluidic devices for drug discovery and delivery applications challenging due to small sample volumes and need for specialized analytical techniques
- Achieving uniform surface properties and channel dimensions across large-area nanofluidic devices
- Developing reliable and cost-effective mass production techniques for commercial applications
- Ensuring long-term and performance of nanofluidic devices under various environmental conditions
Operational and biological challenges
- Scaling effects lead to unexpected fluid behavior (increased viscosity and surface tension) affecting drug transport and interaction kinetics
- Surface fouling and biomolecule adsorption in nanofluidic channels alter device performance over time potentially affecting drug discovery assays and delivery efficiency
- Regulatory hurdles and standardization issues may slow adoption of nanofluidic devices in clinical drug discovery and delivery processes requiring extensive validation and quality control measures
- Maintaining cell viability and functionality in nanofluidic environments for long-term studies
- Addressing potential nanotoxicity concerns associated with nanofluidic materials and structures
- Overcoming limitations in sample preparation and handling for nanoscale volumes
- Developing robust and user-friendly interfaces for operation by non-specialists in clinical settings
Surface chemistry in nanofluidic devices
Electrokinetic phenomena and surface charge
- Surface charge density and distribution in nanofluidic channels significantly influence electrokinetic phenomena exploited for drug separation, concentration, and delivery
- Chemical modification of channel surfaces with functional groups (-COOH, -NH2, -OH) enables tuning of surface properties for specific drug interactions and controlled release mechanisms
- Zeta potential manipulation allows for control of electroosmotic flow and electrophoretic transport of charged drug molecules
- Double layer overlap in leads to unique ion transport phenomena affecting drug behavior
- Surface charge patterning creates localized electric fields for drug trapping and concentration
- pH-responsive surface coatings enable dynamic control of surface charge for smart drug delivery
- Charge-based separation of drug molecules or nanocarriers in nanofluidic channels
Functionalization and biomolecule interactions
- Biomolecule immobilization techniques (covalent attachment, affinity-based capture) allow creation of biorecognition surfaces for drug screening and targeted delivery applications
- Stimuli-responsive surface coatings (pH-sensitive, temperature-sensitive) incorporated for on-demand drug release or capture in response to environmental cues
- Nanostructured surface topographies (nanopillars, nanogrooves) engineered to enhance drug adsorption, cellular interactions, and controlled release kinetics
- Surface functionalization with antifouling materials (PEG, zwitterionic polymers) helps maintain long-term device performance by reducing non-specific adsorption
- Integration of catalytic surfaces or enzyme-functionalized regions enables in situ drug activation or metabolism studies
- Molecularly imprinted polymers create specific binding sites for targeted drug capture and release
- DNA-based surface modifications enable sequence-specific drug interactions and programmable release mechanisms
Nanofluidic devices and personalized medicine
Personalized drug screening and analysis
- Enable rapid and sensitive analysis of individual patient samples facilitating personalized drug screening and selection based on genetic and molecular profiles
- Integration with wearable or implantable technologies allows continuous monitoring of drug levels and real-time adjustment of dosing regimens
- Manipulate and analyze single cells enabling study of drug responses at individual cell level potentially leading to more precise treatments for heterogeneous diseases (cancer)
- Facilitate development of organ-on-a-chip models accurately mimicking patient-specific physiology enabling personalized drug efficacy and toxicity testing
- Support high-throughput screening of patient-derived cells against drug libraries
- Enable real-time monitoring of drug-induced cellular responses at the molecular level
- Provide platforms for studying patient-specific drug metabolism and pharmacokinetics
Advanced drug delivery and monitoring systems
- Nanofluidic platforms used to develop and test novel drug delivery systems (nanocarriers and stimuli-responsive materials) for improved targeting and controlled release
- Miniaturization and automation capabilities lead to development of point-of-care diagnostic and drug monitoring systems improving accessibility to personalized medicine
- Enable creation of smart drug delivery implants combining sensing, decision-making, and controlled release functions for autonomous, patient-specific therapeutic interventions
- Support development of closed-loop drug delivery systems with integrated biosensors
- Facilitate creation of multifunctional nanoparticles for combined imaging and drug delivery
- Enable precise control over drug release kinetics based on individual patient needs
- Provide platforms for studying drug-drug interactions in patient-specific contexts
Key Terms to Review (18)
Bioanalytical Systems: Bioanalytical systems refer to integrated platforms that combine biological and analytical methods to measure and analyze biomolecules, cells, or tissues. These systems are crucial in research and development processes, particularly in the areas of drug discovery and delivery, as they provide precise and sensitive detection of biological interactions and responses.
Bioavailability: Bioavailability refers to the proportion of a drug or substance that enters the systemic circulation when it is introduced into the body and is available for therapeutic effect. In the context of drug discovery and delivery, bioavailability is critical because it determines how much of an administered drug reaches its target site, influencing the drug's efficacy and safety.
Diffusion: Diffusion is the process by which particles spread from an area of higher concentration to an area of lower concentration, driven by the random motion of molecules. In the context of nanoscale systems, diffusion is crucial for understanding how substances move within confined spaces, affecting various applications like drug delivery and single-cell manipulation.
Electrokinetic Flow: Electrokinetic flow refers to the movement of fluid induced by an electric field, which causes charged particles in the fluid to migrate, resulting in the bulk motion of the fluid. This phenomenon is crucial in applications involving nanoscale systems, where the manipulation of fluids at microscopic levels is necessary for processes such as drug delivery, environmental analysis, and device modeling. By utilizing electrokinetic flow, researchers can enhance the efficiency of transport processes in various lab-on-a-chip technologies and improve the performance of nanofluidic devices.
Fluidic Rectification: Fluidic rectification is the process by which fluid flow is allowed to move more easily in one direction than the opposite direction, effectively acting like a one-way valve. This phenomenon is essential in nanofluidic devices, as it can enhance the controlled transport of fluids at the nanoscale, making it particularly valuable for applications in drug discovery and delivery. By utilizing the unique behaviors of fluids at the nanoscale, fluidic rectification contributes to the efficient manipulation and targeted release of drugs within biological systems.
Fluidic Resistance: Fluidic resistance is the opposition that a fluid encounters as it flows through a channel or a porous medium, similar to electrical resistance in circuits. This concept is crucial in micro and nanofluidic systems where the behavior of fluids at small scales differs significantly from macroscopic systems due to effects like viscosity and surface interactions. Understanding fluidic resistance is essential for optimizing device designs and ensuring effective fluid transport in applications like drug delivery and diagnostics.
High-throughput screening: High-throughput screening (HTS) is a process that allows researchers to quickly conduct millions of chemical, genetic, or pharmacological tests through automation and miniaturization. This method enables the rapid identification of active compounds, antibodies, or genes that modulate a particular biomolecular pathway, making it a critical tool in drug discovery, development, and various scientific research areas.
Integrated microfluidics: Integrated microfluidics refers to the technology that combines various fluidic components and functionalities onto a single microchip to manipulate small volumes of fluids with precision. This integration allows for enhanced control over fluid behavior, leading to innovative applications in areas like diagnostics, drug delivery, and biological analysis. The ability to perform multiple functions such as mixing, separation, and detection on one platform streamlines processes and reduces the need for large equipment.
Microfabrication: Microfabrication is the process of fabricating miniature structures and devices, often on the microscale, utilizing techniques from semiconductor manufacturing. This technology is essential for creating components used in various applications, such as nanofluidic devices, sensors, and actuators, enabling advancements in fields like drug discovery and lab-on-a-chip technologies.
Nanochannels: Nanochannels are tiny, cylindrical pathways with diameters in the nanometer range that facilitate the movement of fluids and particles at the nanoscale. They play a crucial role in manipulating fluids in nanofluidic devices, which are essential for various applications like drug delivery, environmental monitoring, and innovative lab-on-a-chip systems.
Nanofluidic Channels: Nanofluidic channels are tiny pathways, often at the nanoscale, that facilitate the movement and manipulation of fluids at the molecular level. These channels leverage unique properties of fluids confined within small dimensions, allowing for enhanced control over fluid dynamics and interactions with biomolecules. The precision of nanofluidic channels makes them vital for applications like targeted drug delivery and understanding biological processes at the cellular level.
Polydimethylsiloxane (PDMS): Polydimethylsiloxane (PDMS) is a silicone-based organic polymer known for its unique properties such as flexibility, chemical stability, and biocompatibility. These characteristics make it an ideal material for use in various applications like microfluidics, lab-on-a-chip devices, and organ-on-a-chip systems, enabling the development of complex biological models and efficient fluid manipulation.
Sample Throughput: Sample throughput refers to the rate at which samples can be processed in a given system or device, indicating the efficiency and speed of that system in handling multiple samples. In the context of nanofluidic devices used for drug discovery and delivery, high sample throughput is critical because it allows for rapid testing and analysis of potential drug candidates, ultimately accelerating the development process. Efficient sample throughput is achieved by optimizing fluidic paths, minimizing dead volumes, and utilizing advanced detection methods.
Scaling Laws: Scaling laws refer to mathematical relationships that describe how different physical quantities change with size or scale. In nanofluidics, these laws are crucial for understanding how systems behave at the nanoscale compared to their macroscopic counterparts, impacting properties like fluid flow, heat transfer, and mass transport. They also help in predicting the performance of nanofluidic devices, especially in applications such as drug discovery and delivery.
Silicon: Silicon is a chemical element with symbol Si and atomic number 14, widely used in electronics and nanotechnology due to its excellent semiconductor properties. Its unique characteristics make it a fundamental material for fabricating various components in modern technology, including nanofluidic devices that are essential for applications ranging from drug delivery to single-molecule studies.
Stability: Stability refers to the ability of a system to maintain its state or return to it after being disturbed. In the context of nanofluidic devices for drug discovery and delivery, stability is crucial because it impacts the performance, efficacy, and reliability of these devices. A stable system ensures that the drug interactions occur as intended, minimizing variability and enhancing predictability in therapeutic outcomes.
Surface modification: Surface modification refers to the process of altering the physical and chemical properties of a material's surface to enhance its performance or functionality. This can involve techniques such as coatings, grafting, or etching, which can significantly affect how materials interact with their environment, such as in drug delivery or sensor applications. By changing surface characteristics like hydrophilicity, roughness, or biocompatibility, researchers can tailor materials for specific applications in various fields.
Targeted Drug Delivery: Targeted drug delivery is a strategy that aims to deliver therapeutic agents directly to specific cells or tissues, enhancing the effectiveness of treatment while minimizing side effects. This method is particularly crucial in fields such as nanofluidics and lab-on-a-chip devices, which allow for precise control over drug release and localization, improving patient outcomes and reducing toxicity.